Citation Impact
Citing Papers
Rhizobium induces DNA damage in Caenorhabditis elegans intestinal cells
2019 StandoutNobel
Management of Adults With Hospital-acquired and Ventilator-associated Pneumonia: 2016 Clinical Practice Guidelines by the Infectious Diseases Society of America and the American Thoracic Society
2016 Standout
Rapid detection of Mycobacterium tuberculosis in sputum with a solvatochromic trehalose probe
2018 StandoutNobel
Value of ampicillin in the hospital treatment of exacerbations of chronic bronchitis.
1965
Imaging Mycobacterial Trehalose Glycolipids
2017 StandoutNobel
Kraken: ultrafast metagenomic sequence classification using exact alignments
2014 Standout
Global Strategy for the Diagnosis, Management, and Prevention of Chronic Obstructive Pulmonary Disease
2007 Standout
Antibiotic regimens in severe and acute purulent exacerbations of chronic bronchitis.
1968
Immunofluorescent localization of immunoglobulins, complement, and fibrinogen in human diseases. I. Systemic lupus erythematosus.
1965
The MyD88-Dependent, but Not the MyD88-Independent, Pathway of TLR4 Signaling Is Important in Clearing Nontypeable Haemophilus influenzae from the Mouse Lung
2005 StandoutNobel
Understanding biofilm resistance to antibacterial agents
2003 Standout
Bacterial Biofilms in Nature and Disease
1987 Standout
Eradication of early Pseudomonas aeruginosa infection
2005
Practice Guidelines for the Management of Community-Acquired Pneumonia in Adults
2000 Standout
Susceptibility to Exacerbation in Chronic Obstructive Pulmonary Disease
2010 Standout
Cystic fibrosis
2016 Standout
Eosinophilic Inflammation in Asthma
1990 Standout
Epidemiology of infection and current guidelines for infection prevention in cystic fibrosis patients
2015
Establishment of infection: lessons from a versatile opportunist
2000
An Official ATS Clinical Practice Guideline: Interpretation of Exhaled Nitric Oxide Levels (F e NO ) for Clinical Applications
2011 Standout
The Body-Mass Index, Airflow Obstruction, Dyspnea, and Exercise Capacity Index in Chronic Obstructive Pulmonary Disease
2004 Standout
Bacterial Infection in Chronic Obstructive Pulmonary Disease
1992
Quorum sensing signal–response systems in Gram-negative bacteria
2016 Standout
Lung disease in cystic fibrosis—an updated concept
1990
Distribution and resistance patterns ofHaemophilus influenzae: A European cooperative study
1988
Bacterial biofilms: from the Natural environment to infectious diseases
2004 Standout
Interpretative strategies for lung function tests
2005 Standout
4 million neonatal deaths: When? Where? Why?
2005 Standout
AI-2-mediated signalling in bacteria
2012
Chronic obstructive pulmonary disease * 6: The aetiology of exacerbations of chronic obstructive pulmonary disease
2003
The Role of Infection in COPD
1998
Predictive Value of Oropharyngeal Cultures for Identifying Lower Airway Bacteria in Cystic Fibrosis Patients
1991
Mycobacterium tuberculosis Rv3406 Is a Type II Alkyl Sulfatase Capable of Sulfate Scavenging
2013 StandoutNobel
Calcium- and Mucin-Binding Proteins of Staphylococci
1993
Pseudomonas aeruginosa Disrupts Caenorhabditis elegans Iron Homeostasis, Causing a Hypoxic Response and Death
2013 StandoutNobel
The Nature of Small-Airway Obstruction in Chronic Obstructive Pulmonary Disease
2004 Standout
Clinical Practice Guidelines and Quality of Care for Older Patients With Multiple Comorbid Diseases
2005 Standout
Strain-specific Immune Response to Haemophilus influenzae in Chronic Obstructive Pulmonary Disease
2003
Global Strategy for the Diagnosis, Management, and Prevention of Chronic Obstructive Pulmonary Disease
2001 Standout
Ventilator-associated Pneumonia
2002 Standout
Guidelines for the Management of Adults with Community-acquired Pneumonia
2001 Standout
Pathophysiology and Management of Pulmonary Infections in Cystic Fibrosis
2003 Standout
Global Strategy for the Diagnosis, Management, and Prevention of Chronic Obstructive Pulmonary Disease
2012 Standout
Moraxella catarrhalis in Chronic Obstructive Pulmonary Disease
2005
Local and Systemic Effects of Intradermal Recombinant Interferon-γ in Patients with Lepromatous Leprosy
1986 StandoutNobel
Antibiotic Therapy in Exacerbations of Chronic Obstructive Pulmonary Disease
1987 Standout
Immune Response to Haemophilus parainfluenzae in Patients with Chronic Obstructive Lung Disease
2000
Acinetobacter baumannii : Emergence of a Successful Pathogen
2008 Standout
Bacteremic hemophilus influenzae pneumonia in adults
1977
An essential role for interferon gamma in resistance to Mycobacterium tuberculosis infection.
1993 Standout
Biofilms: Survival Mechanisms of Clinically Relevant Microorganisms
2002 Standout
Clinical evaluation of eosinophils in the sputum.
1979
Immunologic Investigations of Mucoid Strains of Pseudomonas aeruginosa: Comparison of Susceptibility to Opsonic Antibody in Mucoid and Nonmucoid Strains
1980
Production and Characterization of the Slime Polysaccharide of Pseudomonas aeruginosa
1973
Antibiotic regimens in moderately ill patients with purulent exacerbations of chronic bronchitis
1972
Pulmonary rehabilitation for chronic obstructive pulmonary disease
2015 Standout
Microbial pathogenesis in cystic fibrosis: mucoid Pseudomonas aeruginosa and Burkholderia cepacia
1996 Standout
Anti-Pseudomonas activity in bronchial secretions of patients receiving amikacin or tobramycin as a continuous infusion
1981
Clinical and Bacteriological Responses to Three Antibiotic Regimens for Acute Exacerbations of Cystic Fibrosis: Tlcarcillln-Tobramycin, Azlocillin-Tobramycin, and Azlocillin-Placebo
1983
Nontypable Haemophilus influenzae: A Review of Clinical Aspects, Surface Antigens, and the Human Immune Response to Infection
1987
Antibiotics for exacerbations of chronic obstructive pulmonary disease
2012
Pulmonary disposition of antimicrobial agents: methodological considerations
1992
TREATMENT OF CHRONIC ASTHMA WITH PREDNISOLONE SIGNIFICANCE OF EOSINOPHILS IN THE SPUTUM
1958
Implications of Rewiring Bacterial Quorum Sensing
2007 StandoutNobel
Quantitation of Microorganisms in Sputum
1969
CYSTIC FIBROSIS
1974
Antibiotic Therapy of Acute Exacerbations of Chronic Bronchitis
1982
Ecology of Haemophilus influenzae and Haemophilus parainfluenzae in sputum and saliva and effects of antibiotics on their distribution in patients with lower respiratory tract infections
1993
MUCOID STRAINS OF PSEUDOMONAS AERUGINOSA: THE INFLUENCE OF CULTURE MEDIUM ON THE STABILITY OF MUCUS PRODUCTION
1975
Flagellar and twitching motility are necessary for Pseudomonas aeruginosa biofilm development
1998 Standout
Prophylactic Use of Oxytetracycline for Exacerbations of Chronic Bronchitis
1957
EXACERBATIONS OF CHRONIC BRONCHITIS TREATMENT WITH OXYTETRACYCLINE
1960
Zanvil Alexander Cohn 1926-1993.
1994 StandoutNobel
Alginate synthesis by Pseudomonas aeruginosa: a key pathogenic factor in chronic pulmonary infections of cystic fibrosis patients
1991
Bacterial Diversity in Human Subgingival Plaque
2001 Standout
Antibiotic activity in sputum
1986
Biomaterial-Centered Infection: Microbial Adhesion Versus Tissue Integration
1987 StandoutScience
Pulmonary disposition of antimicrobial agents: in vivo observations and clinical relevance
1992
Role of infection in chronic bronchitis.
1976
SEROLOGICAL TESTS IN DIAGNOSIS OF PRIMARY BILIARY CIRRHOSIS
1965 StandoutNobel
Nasal carriage of Staphylococcus aureus: epidemiology, underlying mechanisms, and associated risks
1997 Standout
The Crisis in Antibiotic Resistance
1992 StandoutScience
Physical Activity and Public Health in Older Adults
2007 Standout
Fluorescence microscopy of tubercle bacilli stained with auramine and rhodamine.
1962
Inhibitory and Bactericidal Effects of Hydrogen Peroxide Production byStreptococcus pneumoniaeon Other Inhabitants of the Upper Respiratory Tract
2000
Binding of staphylococci to mucus in vivo and in vitro
1989
The Involvement of Cell-to-Cell Signals in the Development of a Bacterial Biofilm
1998 StandoutScience
Microbial Biofilms: from Ecology to Molecular Genetics
2000 Standout
Selective media for the quantitation of bacteria in cystic fibrosis sputum
1984
Sputum and blood eosinophils during corticosteroid treatment of acute exacerbations of asthma
1983
A Controlled Study of the Effect of Treatment on Chronic Bronchitis
1967
Longitudinal study of immune response to Pseudomonas aeruginosa antigens in cystic fibrosis
1983
Penetration of Antibiotics into Respiratory Secretions
1981
PRECIPITINS TO KLEBSIELLA AND OTHER ENTEROBACTERIA IN THE SERUM OF PATIENTS WITH CHRONIC RESPIRATORY DISORDERS
1968
IMMUNOLOGICAL STUDIES CONCERNING THE NEPHRITIS OF SYSTEMIC LUPUS ERYTHEMATOSUS
1967 Standout
Avirulence and altered physiological properties of cystic fibrosis strains of Pseudomonas aeruginosa
1985
Role of Infection in Chronic Bronchitis
1975
Lung Infections Associated with Cystic Fibrosis
2002 Standout
Biofilm Formation as Microbial Development
2000 Standout
Immunocytochemical and Serologic Observations in Primary Biliary Cirrhosis
1964
Role of alginate in infection with mucoid Pseudomonas aeruginosa in cystic fibrosis.
1992
Works of J. Robert May being referenced
The bacteriology and chemotherapy of chronic bronchitis
1965
The survival of Haemophilus influenzae and pneumococci in specimens of sputum sent to the laboratory by post
1964
THE BACTERIOLOGY OF CHRONIC BRONCHITIS
1953
CEPHALORIDINE COMPARED WITH PENICILLIN AND STREPTOMYCIN IN EXACERBATIONS OF CHRONIC MUCOPURULENT BRONCHITIS
1968
PATHOGENIC BACTERIA IN CHRONIC BRONCHITIS
1954
Influence of Daily Penicillin, Tetracycline, Erythromycin, and Sulphamethoxypyridazine on Exacerbations of Bronchitis
1964
Ampicillin in the Therapy of Chronic Bronchitis
1964
LONG-TERM OXYTETRACYCLINE (TERRAMYCIN) THERAPY IN ADVANCED CHRONIC RESPIRATORY INFECTIONS
1954
Bacteriology of sputum in chronic bronchitis
1963
Amoxycillin in the treatment of chronic non-tuberculous bronchial infections
1972
LONG-TERM CHEMOTHERAPY IN CHRONIC BRONCHITIS
1956
ANTIBIOTICS IN CHRONIC BRONCHITIS
1953
" INDIRECT PATHOGENICITY " OF PENICILLINASE-PRODUCING ENTEROBACTERIA IN CHRONIC BRONCHIAL INFECTIONS
1969
A study of Hemophilus influenzae precipitins in the serum of working men in relation to smoking habits, bronchial infection, and airway obstruction.
1973
Antibodies to Haemophilus influenzae in the sera of patients with chronic bronchitis
1965
CHEMOTHERAPY OF CHRONIC BRONCHITIS WITH LARGE DOSES OF AMPICILLIN
1964
SPUTUM IN CHRONIC BRONCHITIS
1958
Ampicillin in the Treatment of Haemophilus influenzae Infections of the Respiratory Tract
1964
Bacterial Infection in Cystic Fibrosis
1972
Chemotherapy of Bronchitis
1961
The laboratory background to the use of penicillin in chronic bronchitis and bronchiectasis
1955
THE BACTERIOLOGY OF CHRONIC BRONCHITIS
1952
TREATMENT OF CHRONIC BRONCHITIS WITH AMPICILLIN Some Pharmacological Observations
1965
A micro method for agar-gel precipitin reactions
1962
Detection of acid‐fast organisms in tissue sections by fluorescence microscopy
1960
HÆMOPHILUS INFLUENZÆ PRECIPITINS IN THE SERUM OF PATIENTS WITH CHRONIC BRONCHIAL DISORDERS
1967
BACTERIAL PRECIPITINS 1N SERUM OF PATIENTS WITH CYSTIC FIBROSIS
1968